136 related articles for article (PubMed ID: 15821840)
1. The influence of extracellular acidosis on the effect of IKr blockers.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):67-76. PubMed ID: 15821840
[TBL] [Abstract][Full Text] [Related]
2. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
[TBL] [Abstract][Full Text] [Related]
3. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
[TBL] [Abstract][Full Text] [Related]
4. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of dofetilide block of HERG K+ channels.
Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
[TBL] [Abstract][Full Text] [Related]
6. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
[TBL] [Abstract][Full Text] [Related]
7. Differential recovery of action potential duration and HERG currents from the effects of two methanesulfonamide class III antiarrhythmic agents, KCB-328 and dofetilide.
Lee K; Park JB; Jeon BH; Kim KJ; Ryu PD; Kwon LS; Kim HY
J Cardiovasc Pharmacol; 2003 Nov; 42(5):648-55. PubMed ID: 14576514
[TBL] [Abstract][Full Text] [Related]
8. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
Kiehn J; Lacerda AE; Wible B; Brown AM
Circulation; 1996 Nov; 94(10):2572-9. PubMed ID: 8921803
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
[TBL] [Abstract][Full Text] [Related]
10. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
11. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
Gintant GA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
[TBL] [Abstract][Full Text] [Related]
12. Dofetilide block involves interactions with open and inactivated states of HERG channels.
Weerapura M; Hébert TE; Nattel S
Pflugers Arch; 2002 Feb; 443(4):520-31. PubMed ID: 11907818
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
15. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition.
Lin C; Ke X; Ranade V; Somberg J
Cardiology; 2008; 110(3):145-52. PubMed ID: 18057881
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
17. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide.
Lin C; Ke X; Ranade V; Somberg J
Cardiology; 2008; 110(3):209-16. PubMed ID: 18057887
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
Ficker E; Jarolimek W; Brown AM
Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
[TBL] [Abstract][Full Text] [Related]
19. Comparison of kinetic properties of quinidine and dofetilide block of HERG channels.
Tsujimae K; Suzuki S; Yamada M; Kurachi Y
Eur J Pharmacol; 2004 Jun; 493(1-3):29-40. PubMed ID: 15189761
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites.
Lees-Miller JP; Duan Y; Teng GQ; Duff HJ
Mol Pharmacol; 2000 Feb; 57(2):367-74. PubMed ID: 10648647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]